Cleo Diagnostics Ltd (ASX:COV)

Cleo Diagnostics Statistics

Total Valuation

ASX:COV has a market cap or net worth of AUD 82.12 million. The enterprise value is 72.69 million.

Market Cap	82.12M
Enterprise Value	72.69M

Important Dates

The next estimated earnings date is Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:COV has 136.86 million shares outstanding. The number of shares has increased by 9.53% in one year.

Current Share Class	136.86M
Shares Outstanding	136.86M
Shares Change (YoY)	+9.53%
Shares Change (QoQ)	+24.01%
Owned by Insiders (%)	29.91%
Owned by Institutions (%)	n/a
Float	81.55M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	33.37
PB Ratio	9.30
P/TBV Ratio	9.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-18.03
EV / Sales	29.54
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-28.85

Financial Position

The company has a current ratio of 8.46

Current Ratio	8.46
Quick Ratio	8.39
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -49.57% and return on invested capital (ROIC) is -30.54%.

Return on Equity (ROE)	-49.57%
Return on Assets (ROA)	-27.83%
Return on Invested Capital (ROIC)	-30.54%
Return on Capital Employed (ROCE)	-45.03%
Weighted Average Cost of Capital (WACC)	6.98%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.28
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +8.49% in the last 52 weeks. The beta is 0.50, so ASX:COV's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	+8.49%
50-Day Moving Average	0.65
200-Day Moving Average	0.47
Relative Strength Index (RSI)	42.70
Average Volume (20 Days)	348,983

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:COV had revenue of AUD 2.46 million and -4.03 million in losses. Loss per share was -0.03.

Revenue	2.46M
Gross Profit	2.46M
Operating Income	-3.97M
Pretax Income	-4.03M
Net Income	-4.03M
EBITDA	-3.91M
EBIT	-3.97M
Loss Per Share	-0.03

Balance Sheet

The company has 9.43 million in cash and n/a in debt, with a net cash position of 9.43 million or 0.07 per share.

Cash & Cash Equivalents	9.43M
Total Debt	n/a
Net Cash	9.43M
Net Cash Per Share	0.07
Equity (Book Value)	8.83M
Book Value Per Share	0.07
Working Capital	8.46M

Cash Flow

In the last 12 months, operating cash flow was -2.51 million and capital expenditures -11,693, giving a free cash flow of -2.52 million.

Operating Cash Flow	-2.51M
Capital Expenditures	-11,693
Free Cash Flow	-2.52M
FCF Per Share	-0.02

Margins

Gross margin is 100.00%, with operating and profit margins of -161.52% and -163.86%.

Gross Margin	100.00%
Operating Margin	-161.52%
Pretax Margin	-163.86%
Profit Margin	-163.86%
EBITDA Margin	-158.99%
EBIT Margin	-161.52%
FCF Margin	n/a

Dividends & Yields

ASX:COV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.53%
Shareholder Yield	-9.53%
Earnings Yield	-4.91%
FCF Yield	-3.07%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2